{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:06:12Z","timestamp":1780131972098,"version":"3.54.0"},"reference-count":116,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The research required to establish that psychiatric treatments are effective often depends on collaboration between academic clinical researchers and industry. Some of the goals of clinical practice and those of commercial developers of psychiatric therapies overlap, such as developing safe and effective treatments. However, there might also be incompatible goals; physicians aim to provide the best care they can to their patients, whereas the medical industry ultimately aims to develop therapies that are commercially successful. In some cases, however, clinical research may be aiming both at improved patient care and commercial success. It is in these cases that a conflict of interest (COI) arises. The goal of this study was to identify differences and commonalities regarding COIs between 2 kinds of somatic psychiatric interventions: pharmacological and neurosurgical.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors conducted a study focused on professional concerns regarding pharmacological and neurosurgical psychiatric interventions. They used medical and bioethics journal articles as an indicator of professionals\u2019 concerns and carried out a thematic content analysis of peer-reviewed articles published between 1960 and 2015, using PubMed and Google Scholar.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>One hundred thirty-seven relevant articles were identified, of which 86 papers focused primarily on psychopharmacology and 51 on neurosurgery. The intervention most discussed in the psychiatric neurosurgery data set was deep brain stimulation (n = 42). While there were no significant differences at the level of categories, pharmacological and neurosurgical interventions differ in the underlying themes discussed. Two issues widely discussed in the articles on pharmaceutical interventions, but largely neglected in the neurosurgery articles, were medical professional issues and industry involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>COIs are a neglected issue in the discussion of ethics concerns regarding medical devices in psychiatry. Yet as these interventions become more common, it is important to address them in part through learning from the discussion regarding COIs in the pharmaceutical industry and by developing approaches to address those aspects of COIs that are unique to the medical device industry.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2018.4.focus17399","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T03:37:05Z","timestamp":1533094625000},"page":"E20","source":"Crossref","is-referenced-by-count":6,"title":["Conflicts of interest and industry professional relationships in psychiatric neurosurgery: a comparative literature review"],"prefix":"10.3171","volume":"45","author":[{"given":"Laura Y.","family":"Cabrera","sequence":"first","affiliation":[{"name":"Center for Ethics and Humanities in the Life Sciences and Department of Translational Science & Molecular Medicine, Michigan State University, East Lansing;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden M. K.","family":"Boyce","sequence":"additional","affiliation":[{"name":"Spectrum Health Medical Group, Department of Neurosciences, Grand Rapids;"},{"name":"College of Human Medicine West Michigan, Michigan State University, Grand Rapids;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"McKenzie","sequence":"additional","affiliation":[{"name":"Lyman Briggs College, Michigan State University, East Lansing; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Bluhm","sequence":"additional","affiliation":[{"name":"Lyman Briggs College, Michigan State University, East Lansing; and"},{"name":"Department of Philosophy, Michigan State University, East Lansing, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Psychiatr Bull","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1192\/pb.29.8.302","article-title":"Conflict of interest in psychiatry","volume":"29","author":"Ahmer S","year":"2005","unstructured":"Ahmer S: Conflict of interest in psychiatry. Psychiatr Bull 29:302\u2013304, 200510.1192\/pb.29.8.302"},{"key":"b2","series-title":"Sci Eng Ethics","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11948-007-9011-z","article-title":"A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines","volume":"13","author":"Ancker JS","year":"2007","unstructured":"Ancker JS, Flanagin A: A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics 13:147\u2013157, 20071771772910.1007\/s11948-007-9011-z"},{"key":"b3","series-title":"Ann Intern Med","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/M15-0288","article-title":"Good publication practice for communicating company-sponsored medical research: GPP3","volume":"163","author":"Battisti WP","year":"2015","unstructured":"Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, : Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med 163:461\u2013464, 20152625906710.7326\/M15-0288"},{"key":"b4","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.289.4.454","article-title":"Scope and impact of financial conflicts of interest in biomedical research: a systematic review","volume":"289","author":"Bekelman JE","year":"2003","unstructured":"Bekelman JE, Li Y, Gross CP: Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289:454\u2013465, 200310.1001\/jama.289.4.45412533125"},{"key":"b5","series-title":"Qual Res Psychol","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun V","year":"2006","unstructured":"Braun V, Clarke V: Using thematic analysis in psychology. Qual Res Psychol 3:77\u2013101, 200610.1191\/1478088706qp063oa"},{"key":"b6","series-title":"J Humanist Psychol","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0022167802250729","article-title":"Psychopharmacology and human values","volume":"43","author":"Breggin PR","year":"2003","unstructured":"Breggin PR: Psychopharmacology and human values. J Humanist Psychol 43:34\u201349, 200310.1177\/0022167802250729"},{"key":"b7","series-title":"J Contemp Health Law Policy","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5694\/j.1326-5377.2004.tb05995.x","article-title":"Psychiatric ethics and emerging issues of psychopharmacology in the treatment of depression","volume":"20","author":"Cohan JA","year":"2003","unstructured":"Cohan JA: Psychiatric ethics and emerging issues of psychopharmacology in the treatment of depression. J Contemp Health Law Policy 20:115\u2013172, 20031506792910.5694\/j.1326-5377.2004.tb05995.x"},{"key":"b8","series-title":"Psychother Psychosom","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000214444","article-title":"Conflicts of interest and disclosure in the American Psychiatric Association\u2019s Clinical Practice Guidelines","volume":"78","author":"Cosgrove L","year":"2009","unstructured":"Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J: Conflicts of interest and disclosure in the American Psychiatric Association\u2019s Clinical Practice Guidelines. Psychother Psychosom 78:228\u2013232, 200910.1159\/00021444419401623"},{"key":"b9","series-title":"Psychother Psychosom","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000091772","article-title":"Financial ties between DSM-IV panel members and the pharmaceutical industry","volume":"75","author":"Cosgrove L","year":"2006","unstructured":"Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L: Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychother Psychosom 75:154\u2013160, 200610.1159\/00009177216636630"},{"key":"b10","series-title":"Account Res","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/08989621.2016.1153971","article-title":"Under the influence: the interplay among industry, publishing, and drug regulation","volume":"23","author":"Cosgrove L","year":"2016","unstructured":"Cosgrove L, Vannoy S, Mintzes B, Shaughnessy AF: Under the influence: the interplay among industry, publishing, and drug regulation. Account Res 23:257\u2013279, 201610.1080\/08989621.2016.115397126890488"},{"key":"b11","series-title":"Asian J Psychiatr","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ajp.2011.01.002","article-title":"Pharmaceutical industry and the market: The case of Prozac and other antidepressants","volume":"4","author":"Das A","year":"2011","unstructured":"Das A: Pharmaceutical industry and the market: The case of Prozac and other antidepressants. Asian J Psychiatr 4:14\u201318, 20112305090810.1016\/j.ajp.2011.01.002"},{"key":"b12","unstructured":"The Dr. Oz Show: Transcranial magnetic stimulation: a cure for depression? Pt 2. March 14, 2012. (https:\/\/www.doctoroz.com\/episode\/5-controversial-solutions-your-biggest-complaints?video_id=1848034860001) [Accessed June 14, 2018]"},{"key":"b13","series-title":"Bioethics","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1467-8519.2011.01886.x","article-title":"Ethical concerns regarding commercialization of deep brain stimulation for obsessive compulsive disorder","volume":"26","author":"Erickson-Davis C","year":"2012","unstructured":"Erickson-Davis C: Ethical concerns regarding commercialization of deep brain stimulation for obsessive compulsive disorder. Bioethics 26:440\u2013446, 20122153506310.1111\/j.1467-8519.2011.01886.x"},{"key":"b14","series-title":"Psychother Psychosom","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000074433","article-title":"Conflict of interest in psychopharmacology: can Dr. Jekyll still control Mr. Hyde?","volume":"73","author":"Fava GA","year":"2004","unstructured":"Fava GA: Conflict of interest in psychopharmacology: can Dr. Jekyll still control Mr. Hyde? Psychother Psychosom 73:1\u20134, 200410.1159\/00007443314665789"},{"key":"b15","series-title":"Psychother Psychosom","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000214443","article-title":"The decline of pharmaceutical psychiatry and the increasing role of psychological medicine","volume":"78","author":"Fava GA","year":"2009","unstructured":"Fava GA: The decline of pharmaceutical psychiatry and the increasing role of psychological medicine. Psychother Psychosom 78:220\u2013227, 20091940162210.1159\/000214443"},{"key":"b16","series-title":"Psychother Psychosom","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000092890","article-title":"The intellectual crisis of psychiatric research","volume":"75","author":"Fava GA","year":"2006","unstructured":"Fava GA: The intellectual crisis of psychiatric research. Psychother Psychosom 75:202\u2013208, 20061678576910.1159\/000092890"},{"key":"b17","series-title":"Health Aff (Millwood)","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1377\/hlthaff.2010.0157","article-title":"Misuse of the FDA\u2019s humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder","volume":"30","author":"Fins JJ","year":"2011","unstructured":"Fins JJ, Mayberg HS, Nuttin B, Kubu CS, Galert T, Sturm V, : Misuse of the FDA\u2019s humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff (Millwood) 30:302\u2013311, 201110.1377\/hlthaff.2010.015721289352"},{"key":"b18","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1227\/01.NEU.0000243605.89270.6C","article-title":"Psychosurgery: avoiding an ethical redux while advancing a therapeutic future","volume":"59","author":"Fins JJ","year":"2006","unstructured":"Fins JJ, Rezai AR, Greenberg BD: Psychosurgery: avoiding an ethical redux while advancing a therapeutic future. Neurosurgery 59:713\u2013716, 200610.1227\/01.NEU.0000243605.89270.6C17038936"},{"key":"b19","series-title":"J Clin Ethics","first-page":"125","article-title":"Conflicts of interest in deep brain stimulation research and the ethics of transparency","volume":"21","author":"Fins JJ","year":"2010","unstructured":"Fins JJ, Schiff ND: Conflicts of interest in deep brain stimulation research and the ethics of transparency. J Clin Ethics 21:125\u2013132, 201020866018"},{"key":"b20","series-title":"J Neural Eng","doi-asserted-by":"publisher","first-page":"033001","DOI":"10.1088\/1741-2560\/8\/3\/033001","article-title":"Ethical guidance for the management of conflicts of interest for researchers, engineers and clinicians engaged in the development of therapeutic deep brain stimulation","volume":"8","author":"Fins JJ","year":"2011","unstructured":"Fins JJ, Schlaepfer TE, Nuttin B, Kubu CS, Galert T, Sturm V, : Ethical guidance for the management of conflicts of interest for researchers, engineers and clinicians engaged in the development of therapeutic deep brain stimulation. J Neural Eng 8:033001, 20112155584910.1088\/1741-2560\/8\/3\/033001"},{"key":"b21","series-title":"J Law Med Ethics","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1748-720X.2009.00352.x","article-title":"Vulnerable brains: research ethics and neurosurgical patients","volume":"37","author":"Ford PJ","year":"2009","unstructured":"Ford PJ: Vulnerable brains: research ethics and neurosurgical patients. J Law Med Ethics 37:73\u201382, 200910.1111\/j.1748-720X.2009.00352.x19245604"},{"key":"b22","series-title":"Psychopharmacology (Berl)","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00213-003-1477-z","article-title":"Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies","volume":"171","author":"Frank E","year":"2003","unstructured":"Frank E, Novick DM, Kupfer DJ: Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies. Psychopharmacology (Berl) 171:19\u201326, 200310.1007\/s00213-003-1477-z12721781"},{"key":"b23","series-title":"Acad Psychiatry","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1176\/appi.ap.31.1.32","article-title":"Medical education and the pharmaceutical industry: a review of ethical guidelines and their implications for psychiatric training","volume":"31","author":"Geppert CMA","year":"2007","unstructured":"Geppert CMA: Medical education and the pharmaceutical industry: a review of ethical guidelines and their implications for psychiatric training. Acad Psychiatry 31:32\u201339, 20071724205010.1176\/appi.ap.31.1.32"},{"key":"b24","series-title":"Philos Ethics Humanit Med","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1747-5341-2-26","article-title":"The ethics of clinical innovation in psychopharmacology: challenging traditional bioethics","volume":"2","author":"Ghaemi SN","year":"2007","unstructured":"Ghaemi SN, Goodwin FK: The ethics of clinical innovation in psychopharmacology: challenging traditional bioethics. Philos Ethics Humanit Med 2:26, 200710.1186\/1747-5341-2-2617996065"},{"key":"b25","series-title":"Int J Law Psychiatry","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ijlp.2012.09.007","article-title":"Reflections on ethical issues in psychopharmacology: an American perspective","volume":"35","author":"Gutheil TG","year":"2012","unstructured":"Gutheil TG: Reflections on ethical issues in psychopharmacology: an American perspective. Int J Law Psychiatry 35:387\u2013391, 201210.1016\/j.ijlp.2012.09.00723063110"},{"key":"b26","series-title":"Transcult Psychiatry","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1363461509102284","article-title":"From Amrita to substance D: psychopharmacology, political economy, and technologies of the self","volume":"46","author":"Kirmayer LJ","year":"2009","unstructured":"Kirmayer LJ, Raikhel E: From Amrita to substance D: psychopharmacology, political economy, and technologies of the self. Transcult Psychiatry 46:5\u201315, 200910.1177\/136346150910228419293277"},{"key":"b27","series-title":"Curr Pharm Des","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2174\/138161210791959881","article-title":"Safeguarding children\u2019s rights in psychopharmacological research: ethical and legal issues","volume":"16","author":"K\u00f6lch M","year":"2010","unstructured":"K\u00f6lch M, Ludolph AG, Plener PL, Fangerau H, Vitiello B, Fegert JM: Safeguarding children\u2019s rights in psychopharmacological research: ethical and legal issues. Curr Pharm Des 16:2398\u20132406, 201010.2174\/13816121079195988120513231"},{"key":"b28","series-title":"Sci Eng Ethics","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11948-001-0041-7","article-title":"Conflict of interest policies in science and medical journals: editorial practices and author disclosures","volume":"7","author":"Krimsky S","year":"2001","unstructured":"Krimsky S, Rothenberg LS: Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics 7:205\u2013218, 200110.1007\/s11948-001-0041-711349360"},{"key":"b29","series-title":"Isr J Psychiatry Relat Sci","first-page":"89","article-title":"Commentary: first, do no harm. Then, do some good: ethics and human experimental psychopharmacology","volume":"39","author":"Kristal JH","year":"2002","unstructured":"Kristal JH: Commentary: first, do no harm. Then, do some good: ethics and human experimental psychopharmacology. Isr J Psychiatry Relat Sci 39:89\u201391, 2002"},{"key":"b30","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin J","year":"2003","unstructured":"Lexchin J, Bero LA, Djulbegovic B, Clark O: Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326:1167\u20131170, 20031277561410.1136\/bmj.326.7400.1167"},{"key":"b31","series-title":"Arch Intern Med","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/archinternmed.2010.39","article-title":"The impact of disclosing financial ties in research and clinical care: a systematic review","volume":"170","author":"Licurse A","year":"2010","unstructured":"Licurse A, Barber E, Joffe S, Gross C: The impact of disclosing financial ties in research and clinical care: a systematic review. Arch Intern Med 170:675\u2013682, 201010.1001\/archinternmed.2010.39"},{"key":"b32","article-title":"Qualitative Research Methods: A Data Collector\u2019s Field Guide","author":"Mack N","year":"2006","unstructured":"Mack N, Woodsong C, MacQueen KM, Guest G, Namey E: Qualitative Research Methods: A Data Collector\u2019s Field Guide. Durham, NC: Family Health International, 2006"},{"key":"b33","series-title":"Neuron","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg HS","year":"2005","unstructured":"Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, : Deep brain stimulation for treatment-resistant depression. Neuron 45:651\u2013660, 20051574884110.1016\/j.neuron.2005.02.014"},{"key":"b34","series-title":"J Med Ethics","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jme.2005.013185","article-title":"Ethical issues in psychopharmacology","volume":"32","author":"McHenry L","year":"2006","unstructured":"McHenry L: Ethical issues in psychopharmacology. J Med Ethics 32:405\u2013410, 200610.1136\/jme.2005.01318516816041"},{"key":"b35","series-title":"Int J Clin Pharmacol Biopharm","first-page":"443","article-title":"Ethical problems in clinical psychopharmacology","volume":"16","author":"M\u00fcller-Oerlinghausen B","year":"1978","unstructured":"M\u00fcller-Oerlinghausen B: Ethical problems in clinical psychopharmacology. Int J Clin Pharmacol Biopharm 16:443\u2013450, 1978700905"},{"key":"b36","series-title":"Neuropsychopharmacology","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/sj.npp.1301082","article-title":"VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms","volume":"31","author":"Nemeroff CB","year":"2006","unstructured":"Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, : VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 31:1345\u20131355, 20061664193910.1038\/sj.npp.1301082"},{"key":"b37","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/S0140-6736(99)02376-4","article-title":"Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder","volume":"354","author":"Nuttin B","year":"1999","unstructured":"Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B: Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 354:1526, 19991055150410.1016\/S0140-6736(99)02376-4"},{"key":"b38","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00006123-200208000-00044","article-title":"Deep brain stimulation for psychiatric disorders","volume":"51","author":"Nuttin B","year":"2002","unstructured":"Nuttin B, Gybels J, Cosyns P, Gabriels L, Meyerson B, Andr\u00e9ewitch S, : Deep brain stimulation for psychiatric disorders. Neurosurgery 51:519, 200210.1097\/00006123-200208000-00044"},{"key":"b39","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/jnnp-2013-306580","article-title":"Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders","volume":"85","author":"Nuttin B","year":"2014","unstructured":"Nuttin B, Wu H, Mayberg H, Hariz M, Gabri\u00ebls L, Galert T, : Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders. J Neurol Neurosurg Psychiatry 85:1003\u20131008, 20142444485310.1136\/jnnp-2013-306580"},{"key":"b40","series-title":"Am J Psychiatry","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1176\/appi.ajp.162.10.1957","article-title":"Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry","volume":"162","author":"Perlis RH","year":"2005","unstructured":"Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA: Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 162:1957\u20131960, 200510.1176\/appi.ajp.162.10.195716199844"},{"key":"b41","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM198405033101809","article-title":"Dealing with conflicts of interest","volume":"310","author":"Relman AS","year":"1984","unstructured":"Relman AS: Dealing with conflicts of interest. N Engl J Med 310:1182\u20131183, 198410.1056\/NEJM1984050331018096709012"},{"key":"b42","series-title":"Psychiatric Times","article-title":"Ethical issues in psychopharmacology: considerations for clinical practice","author":"Roberts LW","year":"May 31, 2011","unstructured":"Roberts LW, Jain S: Ethical issues in psychopharmacology: considerations for clinical practice. Psychiatric Times. May 31, 2011. (https:\/\/pro.psychcentral.com\/ethical-issues-in-psychopharmacology-considerations-for-clinical-practice\/) [Accessed June 14, 2018]"},{"key":"b43","series-title":"Med J Aust","first-page":"411","article-title":"The ethics of pharmaceutical industry relationships with medical students","volume":"180","author":"Rogers WA","year":"2004","unstructured":"Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN: The ethics of pharmaceutical industry relationships with medical students. Med J Aust 180:411\u2013414, 200415089733"},{"key":"b44","series-title":"Psychopharmacology (Berl)","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00213-003-1503-1","article-title":"Ethical considerations in psychopharmacological research involving decisionally impaired subjects","volume":"171","author":"Rosenstein DL","year":"2003","unstructured":"Rosenstein DL, Miller FG: Ethical considerations in psychopharmacological research involving decisionally impaired subjects. Psychopharmacology (Berl) 171:92\u201397, 20031277418810.1007\/s00213-003-1503-1"},{"key":"b45","series-title":"Nat Biotechnol","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nbt.3782","article-title":"Situating brain regions among patent rights and moral risks","volume":"35","author":"Roskams-Edris D","year":"2017","unstructured":"Roskams-Edris D, Anderson-Redick S, Kiss ZH, Illes J: Situating brain regions among patent rights and moral risks. Nat Biotechnol 35:119\u2013121, 20172817825210.1038\/nbt.3782"},{"key":"b46","first-page":"1","article-title":"An intro to codes and coding, in: The Coding Manual for Qualitative Researchers","author":"Saldana J","year":"2008","unstructured":"Saldana J: An intro to codes and coding, in: The Coding Manual for Qualitative Researchers. London: SAGE, 2008, pp 1\u201331"},{"key":"b47","series-title":"Ethics Behav","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/10508420802066890","article-title":"The science and ethics of placebo in pediatric psychopharmacology","volume":"18","author":"Scahill L","year":"2008","unstructured":"Scahill L, Solanto M, McGuire J: The science and ethics of placebo in pediatric psychopharmacology. Ethics Behav 18:266\u2013285, 200810.1080\/10508420802066890"},{"key":"b48","series-title":"Front Integr Nuerosci","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnint.2011.00017","article-title":"Ethical issues in deep brain stimulation","volume":"5","author":"Schermer M","year":"2011","unstructured":"Schermer M: Ethical issues in deep brain stimulation. Front Integr Nuerosci 5:17, 201110.3389\/fnint.2011.00017"},{"key":"b49","series-title":"Med Sci Monit","first-page":"CR389","article-title":"The Prozac boom and its placebogenic counterpart\u2014a culturally fashioned phenomenon","volume":"8","author":"Slingsby BT","year":"2002","unstructured":"Slingsby BT: The Prozac boom and its placebogenic counterpart\u2014a culturally fashioned phenomenon. Med Sci Monit 8:CR389\u2013CR393, 2002"},{"key":"b50","series-title":"Am J Psychother","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1176\/appi.psychotherapy.1998.52.1.54","article-title":"Contemporary ethical dilemmas in psychotherapy: cosmetic psychopharmacology and managed care","volume":"52","author":"Sperry L","year":"1998","unstructured":"Sperry L, Prosen H: Contemporary ethical dilemmas in psychotherapy: cosmetic psychopharmacology and managed care. Am J Psychother 52:54\u201363, 199810.1176\/appi.psychotherapy.1998.52.1.549553640"},{"key":"b51","series-title":"Int J Neuropsychopharmacol","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/S1461145710001112","article-title":"Ethical considerations in clinical training, care and research in psychopharmacology","volume":"14","author":"Strous RD","year":"2011","unstructured":"Strous RD: Ethical considerations in clinical training, care and research in psychopharmacology. Int J Neuropsychopharmacol 14:413\u2013424, 20112086087910.1017\/S1461145710001112"},{"key":"b52","series-title":"Med Health Care Philos","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11019-007-9057-3","article-title":"Psychopharmacology and the self: an introduction to the theme","volume":"10","author":"Svenaeus F","year":"2007","unstructured":"Svenaeus F: Psychopharmacology and the self: an introduction to the theme. Med Health Care Philos 10:115\u2013117, 20071749722710.1007\/s11019-007-9057-3"},{"key":"b53","series-title":"Child Adolesc Psychiatry Ment Health","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1753-2000-2-39","article-title":"The ethics of psychopharmacological research in legal minors","volume":"2","author":"Tan JOA","year":"2008","unstructured":"Tan JOA, Koelch M: The ethics of psychopharmacological research in legal minors. Child Adolesc Psychiatry Ment Health 2:39, 200810.1186\/1753-2000-2-3919063724"},{"key":"b54","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1056\/NEJM199308193290812","article-title":"Understanding financial conflicts of interest","volume":"329","author":"Thompson DF","year":"1993","unstructured":"Thompson DF: Understanding financial conflicts of interest. N Engl J Med 329:573\u2013576, 199310.1056\/NEJM1993081932908128336759"},{"key":"b55","series-title":"Eur Neuropsychopharmacol","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.euroneuro.2012.03.005","article-title":"Those famous red pills\u2014deliberations and hesitations. Ethics of placebo use in therapeutic and research settings","volume":"22","author":"Touwen DP","year":"2012","unstructured":"Touwen DP, Engberts DP: Those famous red pills\u2014deliberations and hesitations. Ethics of placebo use in therapeutic and research settings. Eur Neuropsychopharmacol 22:775\u2013781, 201210.1016\/j.euroneuro.2012.03.00522534614"},{"key":"b56","article-title":"The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness","author":"Valenstein ES","year":"1986","unstructured":"Valenstein ES: Great and Desperate Cures: The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness. New York: Basic Books, 1986"},{"key":"b57","series-title":"Acad Psychiatry","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1176\/appi.ap.29.1.40","article-title":"A survey of the interactions between psychiatry residency programs and the pharmaceutical industry","volume":"29","author":"Varley CK","year":"2005","unstructured":"Varley CK, Jibson MD, McCarthy M, Benjamin S: A survey of the interactions between psychiatry residency programs and the pharmaceutical industry. Acad Psychiatry 29:40\u201346, 20051577240310.1176\/appi.ap.29.1.40"},{"key":"b58","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jama.283.3.373","article-title":"Physicians and the pharmaceutical industry: is a gift ever just a gift?","volume":"283","author":"Wazana A","year":"2000","unstructured":"Wazana A: Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 283:373\u2013380, 200010.1001\/jama.283.3.37310647801"},{"key":"b1","series-title":"Psychiatr Bull","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1192\/pb.29.8.302","article-title":"Conflict of interest in psychiatry","volume":"29","author":"Ahmer S","year":"2005","unstructured":"Ahmer S: Conflict of interest in psychiatry. Psychiatr Bull 29:302\u2013304, 200510.1192\/pb.29.8.302"},{"key":"b2","series-title":"Sci Eng Ethics","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11948-007-9011-z","article-title":"A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines","volume":"13","author":"Ancker JS","year":"2007","unstructured":"Ancker JS, Flanagin A: A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics 13:147\u2013157, 20071771772910.1007\/s11948-007-9011-z"},{"key":"b3","series-title":"Ann Intern Med","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/M15-0288","article-title":"Good publication practice for communicating company-sponsored medical research: GPP3","volume":"163","author":"Battisti WP","year":"2015","unstructured":"Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, : Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med 163:461\u2013464, 20152625906710.7326\/M15-0288"},{"key":"b4","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1001\/jama.289.4.454","article-title":"Scope and impact of financial conflicts of interest in biomedical research: a systematic review","volume":"289","author":"Bekelman JE","year":"2003","unstructured":"Bekelman JE, Li Y, Gross CP: Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289:454\u2013465, 200310.1001\/jama.289.4.45412533125"},{"key":"b5","series-title":"Qual Res Psychol","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun V","year":"2006","unstructured":"Braun V, Clarke V: Using thematic analysis in psychology. Qual Res Psychol 3:77\u2013101, 200610.1191\/1478088706qp063oa"},{"key":"b6","series-title":"J Humanist Psychol","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0022167802250729","article-title":"Psychopharmacology and human values","volume":"43","author":"Breggin PR","year":"2003","unstructured":"Breggin PR: Psychopharmacology and human values. J Humanist Psychol 43:34\u201349, 200310.1177\/0022167802250729"},{"key":"b7","series-title":"J Contemp Health Law Policy","first-page":"115","article-title":"Psychiatric ethics and emerging issues of psychopharmacology in the treatment of depression","volume":"20","author":"Cohan JA","year":"2003","unstructured":"Cohan JA: Psychiatric ethics and emerging issues of psychopharmacology in the treatment of depression. J Contemp Health Law Policy 20:115\u2013172, 200315067929"},{"key":"b8","series-title":"Psychother Psychosom","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000214444","article-title":"Conflicts of interest and disclosure in the American Psychiatric Association\u2019s Clinical Practice Guidelines","volume":"78","author":"Cosgrove L","year":"2009","unstructured":"Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J: Conflicts of interest and disclosure in the American Psychiatric Association\u2019s Clinical Practice Guidelines. Psychother Psychosom 78:228\u2013232, 200910.1159\/00021444419401623"},{"key":"b9","series-title":"Psychother Psychosom","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000091772","article-title":"Financial ties between DSM-IV panel members and the pharmaceutical industry","volume":"75","author":"Cosgrove L","year":"2006","unstructured":"Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L: Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychother Psychosom 75:154\u2013160, 200610.1159\/00009177216636630"},{"key":"b10","series-title":"Account Res","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/08989621.2016.1153971","article-title":"Under the influence: the interplay among industry, publishing, and drug regulation","volume":"23","author":"Cosgrove L","year":"2016","unstructured":"Cosgrove L, Vannoy S, Mintzes B, Shaughnessy AF: Under the influence: the interplay among industry, publishing, and drug regulation. Account Res 23:257\u2013279, 201610.1080\/08989621.2016.115397126890488"},{"key":"b11","series-title":"Asian J Psychiatr","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ajp.2011.01.002","article-title":"Pharmaceutical industry and the market: The case of Prozac and other antidepressants","volume":"4","author":"Das A","year":"2011","unstructured":"Das A: Pharmaceutical industry and the market: The case of Prozac and other antidepressants. Asian J Psychiatr 4:14\u201318, 20112305090810.1016\/j.ajp.2011.01.002"},{"key":"b12","unstructured":"The Dr. Oz Show: Transcranial magnetic stimulation: a cure for depression? Pt 2. March 14, 2012. (https:\/\/www.doctoroz.com\/episode\/5-controversial-solutions-your-biggest-complaints?video_id=1848034860001) [Accessed June 14, 2018]"},{"key":"b13","series-title":"Bioethics","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1467-8519.2011.01886.x","article-title":"Ethical concerns regarding commercialization of deep brain stimulation for obsessive compulsive disorder","volume":"26","author":"Erickson-Davis C","year":"2012","unstructured":"Erickson-Davis C: Ethical concerns regarding commercialization of deep brain stimulation for obsessive compulsive disorder. Bioethics 26:440\u2013446, 20122153506310.1111\/j.1467-8519.2011.01886.x"},{"key":"b14","series-title":"Psychother Psychosom","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000074433","article-title":"Conflict of interest in psychopharmacology: can Dr. Jekyll still control Mr. Hyde?","volume":"73","author":"Fava GA","year":"2004","unstructured":"Fava GA: Conflict of interest in psychopharmacology: can Dr. Jekyll still control Mr. Hyde? Psychother Psychosom 73:1\u20134, 200410.1159\/00007443314665789"},{"key":"b15","series-title":"Psychother Psychosom","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000214443","article-title":"The decline of pharmaceutical psychiatry and the increasing role of psychological medicine","volume":"78","author":"Fava GA","year":"2009","unstructured":"Fava GA: The decline of pharmaceutical psychiatry and the increasing role of psychological medicine. Psychother Psychosom 78:220\u2013227, 20091940162210.1159\/000214443"},{"key":"b16","series-title":"Psychother Psychosom","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000092890","article-title":"The intellectual crisis of psychiatric research","volume":"75","author":"Fava GA","year":"2006","unstructured":"Fava GA: The intellectual crisis of psychiatric research. Psychother Psychosom 75:202\u2013208, 20061678576910.1159\/000092890"},{"key":"b17","series-title":"Health Aff (Millwood)","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1377\/hlthaff.2010.0157","article-title":"Misuse of the FDA\u2019s humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder","volume":"30","author":"Fins JJ","year":"2011","unstructured":"Fins JJ, Mayberg HS, Nuttin B, Kubu CS, Galert T, Sturm V, : Misuse of the FDA\u2019s humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff (Millwood) 30:302\u2013311, 201110.1377\/hlthaff.2010.015721289352"},{"key":"b18","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1227\/01.NEU.0000243605.89270.6C","article-title":"Psychosurgery: avoiding an ethical redux while advancing a therapeutic future","volume":"59","author":"Fins JJ","year":"2006","unstructured":"Fins JJ, Rezai AR, Greenberg BD: Psychosurgery: avoiding an ethical redux while advancing a therapeutic future. Neurosurgery 59:713\u2013716, 200610.1227\/01.NEU.0000243605.89270.6C17038936"},{"key":"b19","series-title":"J Clin Ethics","first-page":"125","article-title":"Conflicts of interest in deep brain stimulation research and the ethics of transparency","volume":"21","author":"Fins JJ","year":"2010","unstructured":"Fins JJ, Schiff ND: Conflicts of interest in deep brain stimulation research and the ethics of transparency. J Clin Ethics 21:125\u2013132, 201020866018"},{"key":"b20","series-title":"J Neural Eng","doi-asserted-by":"publisher","first-page":"033001","DOI":"10.1088\/1741-2560\/8\/3\/033001","article-title":"Ethical guidance for the management of conflicts of interest for researchers, engineers and clinicians engaged in the development of therapeutic deep brain stimulation","volume":"8","author":"Fins JJ","year":"2011","unstructured":"Fins JJ, Schlaepfer TE, Nuttin B, Kubu CS, Galert T, Sturm V, : Ethical guidance for the management of conflicts of interest for researchers, engineers and clinicians engaged in the development of therapeutic deep brain stimulation. J Neural Eng 8:033001, 20112155584910.1088\/1741-2560\/8\/3\/033001"},{"key":"b21","series-title":"J Law Med Ethics","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1748-720X.2009.00352.x","article-title":"Vulnerable brains: research ethics and neurosurgical patients","volume":"37","author":"Ford PJ","year":"2009","unstructured":"Ford PJ: Vulnerable brains: research ethics and neurosurgical patients. J Law Med Ethics 37:73\u201382, 200910.1111\/j.1748-720X.2009.00352.x19245604"},{"key":"b22","series-title":"Psychopharmacology (Berl)","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00213-003-1477-z","article-title":"Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies","volume":"171","author":"Frank E","year":"2003","unstructured":"Frank E, Novick DM, Kupfer DJ: Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies. Psychopharmacology (Berl) 171:19\u201326, 200310.1007\/s00213-003-1477-z12721781"},{"key":"b23","series-title":"Acad Psychiatry","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1176\/appi.ap.31.1.32","article-title":"Medical education and the pharmaceutical industry: a review of ethical guidelines and their implications for psychiatric training","volume":"31","author":"Geppert CMA","year":"2007","unstructured":"Geppert CMA: Medical education and the pharmaceutical industry: a review of ethical guidelines and their implications for psychiatric training. Acad Psychiatry 31:32\u201339, 20071724205010.1176\/appi.ap.31.1.32"},{"key":"b24","series-title":"Philos Ethics Humanit Med","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1747-5341-2-26","article-title":"The ethics of clinical innovation in psychopharmacology: challenging traditional bioethics","volume":"2","author":"Ghaemi SN","year":"2007","unstructured":"Ghaemi SN, Goodwin FK: The ethics of clinical innovation in psychopharmacology: challenging traditional bioethics. Philos Ethics Humanit Med 2:26, 200710.1186\/1747-5341-2-2617996065"},{"key":"b25","series-title":"Int J Law Psychiatry","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ijlp.2012.09.007","article-title":"Reflections on ethical issues in psychopharmacology: an American perspective","volume":"35","author":"Gutheil TG","year":"2012","unstructured":"Gutheil TG: Reflections on ethical issues in psychopharmacology: an American perspective. Int J Law Psychiatry 35:387\u2013391, 201210.1016\/j.ijlp.2012.09.00723063110"},{"key":"b26","series-title":"Transcult Psychiatry","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1363461509102284","article-title":"From Amrita to substance D: psychopharmacology, political economy, and technologies of the self","volume":"46","author":"Kirmayer LJ","year":"2009","unstructured":"Kirmayer LJ, Raikhel E: From Amrita to substance D: psychopharmacology, political economy, and technologies of the self. Transcult Psychiatry 46:5\u201315, 200910.1177\/136346150910228419293277"},{"key":"b27","series-title":"Curr Pharm Des","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2174\/138161210791959881","article-title":"Safeguarding children\u2019s rights in psychopharmacological research: ethical and legal issues","volume":"16","author":"K\u00f6lch M","year":"2010","unstructured":"K\u00f6lch M, Ludolph AG, Plener PL, Fangerau H, Vitiello B, Fegert JM: Safeguarding children\u2019s rights in psychopharmacological research: ethical and legal issues. Curr Pharm Des 16:2398\u20132406, 201010.2174\/13816121079195988120513231"},{"key":"b28","series-title":"Sci Eng Ethics","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11948-001-0041-7","article-title":"Conflict of interest policies in science and medical journals: editorial practices and author disclosures","volume":"7","author":"Krimsky S","year":"2001","unstructured":"Krimsky S, Rothenberg LS: Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics 7:205\u2013218, 200110.1007\/s11948-001-0041-711349360"},{"key":"b29","series-title":"Isr J Psychiatry Relat Sci","first-page":"89","article-title":"Commentary: first, do no harm. Then, do some good: ethics and human experimental psychopharmacology","volume":"39","author":"Kristal JH","year":"2002","unstructured":"Kristal JH: Commentary: first, do no harm. Then, do some good: ethics and human experimental psychopharmacology. Isr J Psychiatry Relat Sci 39:89\u201391, 2002"},{"key":"b30","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin J","year":"2003","unstructured":"Lexchin J, Bero LA, Djulbegovic B, Clark O: Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326:1167\u20131170, 20031277561410.1136\/bmj.326.7400.1167"},{"key":"b31","series-title":"Arch Intern Med","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/archinternmed.2010.39","article-title":"The impact of disclosing financial ties in research and clinical care: a systematic review","volume":"170","author":"Licurse A","year":"2010","unstructured":"Licurse A, Barber E, Joffe S, Gross C: The impact of disclosing financial ties in research and clinical care: a systematic review. Arch Intern Med 170:675\u2013682, 201010.1001\/archinternmed.2010.39"},{"key":"b32","article-title":"Qualitative Research Methods: A Data Collector\u2019s Field Guide","author":"Mack N","year":"2006","unstructured":"Mack N, Woodsong C, MacQueen KM, Guest G, Namey E: Qualitative Research Methods: A Data Collector\u2019s Field Guide. Durham, NC: Family Health International, 2006"},{"key":"b33","series-title":"Neuron","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.neuron.2005.02.014","article-title":"Deep brain stimulation for treatment-resistant depression","volume":"45","author":"Mayberg HS","year":"2005","unstructured":"Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, : Deep brain stimulation for treatment-resistant depression. Neuron 45:651\u2013660, 20051574884110.1016\/j.neuron.2005.02.014"},{"key":"b34","series-title":"J Med Ethics","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jme.2005.013185","article-title":"Ethical issues in psychopharmacology","volume":"32","author":"McHenry L","year":"2006","unstructured":"McHenry L: Ethical issues in psychopharmacology. J Med Ethics 32:405\u2013410, 200610.1136\/jme.2005.01318516816041"},{"key":"b35","series-title":"Int J Clin Pharmacol Biopharm","first-page":"443","article-title":"Ethical problems in clinical psychopharmacology","volume":"16","author":"M\u00fcller-Oerlinghausen B","year":"1978","unstructured":"M\u00fcller-Oerlinghausen B: Ethical problems in clinical psychopharmacology. Int J Clin Pharmacol Biopharm 16:443\u2013450, 1978700905"},{"key":"b36","series-title":"Neuropsychopharmacology","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/sj.npp.1301082","article-title":"VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms","volume":"31","author":"Nemeroff CB","year":"2006","unstructured":"Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, : VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 31:1345\u20131355, 20061664193910.1038\/sj.npp.1301082"},{"key":"b37","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/S0140-6736(99)02376-4","article-title":"Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder","volume":"354","author":"Nuttin B","year":"1999","unstructured":"Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B: Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 354:1526, 19991055150410.1016\/S0140-6736(99)02376-4"},{"key":"b38","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00006123-200208000-00044","article-title":"Deep brain stimulation for psychiatric disorders","volume":"51","author":"Nuttin B","year":"2002","unstructured":"Nuttin B, Gybels J, Cosyns P, Gabriels L, Meyerson B, Andr\u00e9ewitch S, : Deep brain stimulation for psychiatric disorders. Neurosurgery 51:519, 200210.1097\/00006123-200208000-00044"},{"key":"b39","series-title":"J Neurol Neurosurg Psychiatry","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/jnnp-2013-306580","article-title":"Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders","volume":"85","author":"Nuttin B","year":"2014","unstructured":"Nuttin B, Wu H, Mayberg H, Hariz M, Gabri\u00ebls L, Galert T, : Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders. J Neurol Neurosurg Psychiatry 85:1003\u20131008, 20142444485310.1136\/jnnp-2013-306580"},{"key":"b40","series-title":"Am J Psychiatry","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1176\/appi.ajp.162.10.1957","article-title":"Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry","volume":"162","author":"Perlis RH","year":"2005","unstructured":"Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA: Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 162:1957\u20131960, 200510.1176\/appi.ajp.162.10.195716199844"},{"key":"b41","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM198405033101809","article-title":"Dealing with conflicts of interest","volume":"310","author":"Relman AS","year":"1984","unstructured":"Relman AS: Dealing with conflicts of interest. N Engl J Med 310:1182\u20131183, 198410.1056\/NEJM1984050331018096709012"},{"key":"b42","series-title":"Psychiatric Times","article-title":"Ethical issues in psychopharmacology: considerations for clinical practice","author":"Roberts LW","year":"May 31, 2011","unstructured":"Roberts LW, Jain S: Ethical issues in psychopharmacology: considerations for clinical practice. Psychiatric Times. May 31, 2011. (https:\/\/pro.psychcentral.com\/ethical-issues-in-psychopharmacology-considerations-for-clinical-practice\/) [Accessed June 14, 2018]"},{"key":"b43","series-title":"Med J Aust","first-page":"411","article-title":"The ethics of pharmaceutical industry relationships with medical students","volume":"180","author":"Rogers WA","year":"2004","unstructured":"Rogers WA, Mansfield PR, Braunack-Mayer AJ, Jureidini JN: The ethics of pharmaceutical industry relationships with medical students. Med J Aust 180:411\u2013414, 200415089733"},{"key":"b44","series-title":"Psychopharmacology (Berl)","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00213-003-1503-1","article-title":"Ethical considerations in psychopharmacological research involving decisionally impaired subjects","volume":"171","author":"Rosenstein DL","year":"2003","unstructured":"Rosenstein DL, Miller FG: Ethical considerations in psychopharmacological research involving decisionally impaired subjects. Psychopharmacology (Berl) 171:92\u201397, 20031277418810.1007\/s00213-003-1503-1"},{"key":"b45","series-title":"Nat Biotechnol","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nbt.3782","article-title":"Situating brain regions among patent rights and moral risks","volume":"35","author":"Roskams-Edris D","year":"2017","unstructured":"Roskams-Edris D, Anderson-Redick S, Kiss ZH, Illes J: Situating brain regions among patent rights and moral risks. Nat Biotechnol 35:119\u2013121, 20172817825210.1038\/nbt.3782"},{"key":"b46","first-page":"1","article-title":"An intro to codes and coding, in: The Coding Manual for Qualitative Researchers","author":"Saldana J","year":"2008","unstructured":"Saldana J: An intro to codes and coding, in: The Coding Manual for Qualitative Researchers. London: SAGE, 2008, pp 1\u201331"},{"key":"b47","series-title":"Ethics Behav","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/10508420802066890","article-title":"The science and ethics of placebo in pediatric psychopharmacology","volume":"18","author":"Scahill L","year":"2008","unstructured":"Scahill L, Solanto M, McGuire J: The science and ethics of placebo in pediatric psychopharmacology. Ethics Behav 18:266\u2013285, 200810.1080\/10508420802066890"},{"key":"b48","series-title":"Front Integr Nuerosci","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnint.2011.00017","article-title":"Ethical issues in deep brain stimulation","volume":"5","author":"Schermer M","year":"2011","unstructured":"Schermer M: Ethical issues in deep brain stimulation. Front Integr Nuerosci 5:17, 201110.3389\/fnint.2011.00017"},{"key":"b49","series-title":"Med Sci Monit","first-page":"CR389","article-title":"The Prozac boom and its placebogenic counterpart\u2014a culturally fashioned phenomenon","volume":"8","author":"Slingsby BT","year":"2002","unstructured":"Slingsby BT: The Prozac boom and its placebogenic counterpart\u2014a culturally fashioned phenomenon. Med Sci Monit 8:CR389\u2013CR393, 2002"},{"key":"b50","series-title":"Am J Psychother","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1176\/appi.psychotherapy.1998.52.1.54","article-title":"Contemporary ethical dilemmas in psychotherapy: cosmetic psychopharmacology and managed care","volume":"52","author":"Sperry L","year":"1998","unstructured":"Sperry L, Prosen H: Contemporary ethical dilemmas in psychotherapy: cosmetic psychopharmacology and managed care. Am J Psychother 52:54\u201363, 199810.1176\/appi.psychotherapy.1998.52.1.549553640"},{"key":"b51","series-title":"Int J Neuropsychopharmacol","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/S1461145710001112","article-title":"Ethical considerations in clinical training, care and research in psychopharmacology","volume":"14","author":"Strous RD","year":"2011","unstructured":"Strous RD: Ethical considerations in clinical training, care and research in psychopharmacology. Int J Neuropsychopharmacol 14:413\u2013424, 20112086087910.1017\/S1461145710001112"},{"key":"b52","series-title":"Med Health Care Philos","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11019-007-9057-3","article-title":"Psychopharmacology and the self: an introduction to the theme","volume":"10","author":"Svenaeus F","year":"2007","unstructured":"Svenaeus F: Psychopharmacology and the self: an introduction to the theme. Med Health Care Philos 10:115\u2013117, 20071749722710.1007\/s11019-007-9057-3"},{"key":"b53","series-title":"Child Adolesc Psychiatry Ment Health","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1753-2000-2-39","article-title":"The ethics of psychopharmacological research in legal minors","volume":"2","author":"Tan JOA","year":"2008","unstructured":"Tan JOA, Koelch M: The ethics of psychopharmacological research in legal minors. Child Adolesc Psychiatry Ment Health 2:39, 200810.1186\/1753-2000-2-3919063724"},{"key":"b54","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1056\/NEJM199308193290812","article-title":"Understanding financial conflicts of interest","volume":"329","author":"Thompson DF","year":"1993","unstructured":"Thompson DF: Understanding financial conflicts of interest. N Engl J Med 329:573\u2013576, 199310.1056\/NEJM1993081932908128336759"},{"key":"b55","series-title":"Eur Neuropsychopharmacol","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.euroneuro.2012.03.005","article-title":"Those famous red pills\u2014deliberations and hesitations. Ethics of placebo use in therapeutic and research settings","volume":"22","author":"Touwen DP","year":"2012","unstructured":"Touwen DP, Engberts DP: Those famous red pills\u2014deliberations and hesitations. Ethics of placebo use in therapeutic and research settings. Eur Neuropsychopharmacol 22:775\u2013781, 201210.1016\/j.euroneuro.2012.03.00522534614"},{"key":"b56","article-title":"The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness","author":"Valenstein ES","year":"1986","unstructured":"Valenstein ES: Great and Desperate Cures: The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness. New York: Basic Books, 1986"},{"key":"b57","series-title":"Acad Psychiatry","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1176\/appi.ap.29.1.40","article-title":"A survey of the interactions between psychiatry residency programs and the pharmaceutical industry","volume":"29","author":"Varley CK","year":"2005","unstructured":"Varley CK, Jibson MD, McCarthy M, Benjamin S: A survey of the interactions between psychiatry residency programs and the pharmaceutical industry. Acad Psychiatry 29:40\u201346, 20051577240310.1176\/appi.ap.29.1.40"},{"key":"b58","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jama.283.3.373","article-title":"Physicians and the pharmaceutical industry: is a gift ever just a gift?","volume":"283","author":"Wazana A","year":"2000","unstructured":"Wazana A: Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 283:373\u2013380, 200010.1001\/jama.283.3.37310647801"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/45\/2\/article-pE20.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/45\/2\/article-pE20.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/45\/2\/article-pE20.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:54:43Z","timestamp":1780131283000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/45\/2\/article-pE20.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":116,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2018.4.focus17399","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}